I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Ucoceko >99.5% EE >99.5%
Ruifu Chemical Supply Related Intermediates
I-CAS 361442-04-8
I-CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
I-2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Igama leMchiza | I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine |
Izithethantonye | (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl)acetic Acid |
Inombolo yeCAS | 361442-00-4 |
Inombolo yeCAT | RF-PI1989 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C17H27NO5 |
Ubunzima beMolekyuli | 325.40 |
Indawo yokubilisa | 497.3±20.0℃ |
Ukuxinana | 1.296 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye oMhlophe |
Amanzi (KF) | <0.50% |
Ilahleko ekomisweni | <1.00% |
Intsalela kwi-Ignition | <0.50% |
Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <0.50% |
EE | >99.5% |
Ubunyulu | >99.5% |
I-Infrared Spectrum | Iyahambelana neSakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) iphakathi kwe-API (CAS: 361442-04-8).API (CAS: 361442-04-8)sisithinteli esinamandla nesikhethayo sokubuyisela i-dipeptidyl peptidase-4, ephuhliswa kunyango lwe-2 seswekile.Ifunxwa ngokukhawuleza emva kokulawulwa komlomo kwaye ineprofayili ye-pharmacokinetic ehambelana ne-dosing kanye ngosuku.Yi-dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic kunyango lwe-2 yeswekile.I-DPP-4 inhibitors yiklasi yeekhompawundi ezisebenza ngokuchaphazela isenzo sehomoni yendalo emzimbeni obizwa ngokuba yi-incretins.Yonaisetyenziswa kunye nokutya kunye nokuzivocavoca ukuphucula ulawulo lweswekile yegazi kubantu abadala abane-type 2 yeswekile mellitus.Asiyonto yokunyanga isifo seswekile se-1.Yonangamanye amaxesha isetyenziswa kunye namanye amayeza eswekile.Ifikelelwe yintsebenziswano ye-AstraZeneca kunye ne-Bristol-Myers Squibb Inkampani kwaye ingeye-DPP-IV inhibitor.